Literature DB >> 15167656

Studies of human intervertebral disc cell function in a constrained in vitro tissue culture system.

Christine Lyn Le Maitre1, Judith Alison Hoyland, Anthony J Freemont.   

Abstract

STUDY
DESIGN: This is a laboratory-based study examining a novel in vitro culture system for intervertebral disc tissue.
OBJECTIVES: Address the hypothesis that "the novel culture system will preserve intervertebral disc tissue matrix and cell function and prevent cellular apoptosis for periods up to 21 days." SUMMARY OF BACKGROUND DATA: Studies of cell function in human intervertebral disc tissue are scarce. In vivo study of human intervertebral disc cells remains impracticable; in situ molecular biology in histologic sections lacks a dynamic dimension; and as for in vitro studies, cell culture often lacks physiologic relevance and explant cultures are subject to loss of tissue integrity and altered cell behavior. There is a biologic and therapeutic need for a satisfactory explant culture system for studying human intervertebral disc tissue in a controlled environment.
METHODS: Samples of human intervertebral disc tissue, obtained at surgery, were examined for a number of tissue and cell parameters immediately after excision (controls) and following culture of tissue samples either in a plastic ring or unconstrained in tissue culture medium for up to 3 weeks. Data were compared between cultured tissue and controls.
RESULTS: By comparison with control tissue, unconstrained explants swelled, tissue structure was disturbed, and there were profound changes in cell function. By contrast, tissue cultured in plastic rings maintained tissue structure, and after 3 weeks, the cellular parameters were the same as in controls.
CONCLUSIONS: This is the first reported system to preserve cell function of human discal explants for long periods in tissue culture. It will be a useful tool for a wide range of investigations of intervertebral disc biology that have not hitherto been possible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167656     DOI: 10.1097/00007632-200406010-00006

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  17 in total

1.  A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.

Authors:  Christine L Le Maitre; Anthony J Freemont; Judith A Hoyland
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  An in vitro tissue model to study the effect of age on nucleus pulposus cells.

Authors:  R A Kandel; D Hamilton; C Séguin; S-Q Li; C Arana; R Pilliar
Journal:  Eur Spine J       Date:  2007-08-18       Impact factor: 3.134

Review 3.  New challenges for intervertebral disc treatment using regenerative medicine.

Authors:  Koichi Masuda; Jeffrey C Lotz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

4.  Development of an in vitro model to test the efficacy of novel therapies for IVD degeneration.

Authors:  Christine L Le Maitre; Andrew P Fotheringham; Anthony J Freemont; Judith A Hoyland
Journal:  J Tissue Eng Regen Med       Date:  2009-08       Impact factor: 3.963

5.  An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue.

Authors:  Christine L Le Maitre; Pauline Baird; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-02-11       Impact factor: 5.156

6.  Effects of TGF-beta1 and IGF-1 on proliferation of human nucleus pulposus cells in medium with different serum concentrations.

Authors:  Rongfeng Zhang; Dike Ruan; Chao Zhang
Journal:  J Orthop Surg Res       Date:  2006-10-26       Impact factor: 2.359

7.  The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.

Authors:  Christine Lyn Le Maitre; Anthony J Freemont; Judith Alison Hoyland
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

Review 8.  Stem cell regeneration of degenerated intervertebral discs: current status.

Authors:  Stephen M Richardson; Judith A Hoyland
Journal:  Curr Pain Headache Rep       Date:  2008-04

9.  Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation.

Authors:  Stéphane Genevay; Axel Finckh; Françoise Mezin; Enrico Tessitore; Pierre-André Guerne
Journal:  Arthritis Res Ther       Date:  2009-11-11       Impact factor: 5.156

10.  Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.

Authors:  Christine L Le Maitre; Judith A Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.